Congratulations to Charles and Lilly on the BRIDGE Discovery grant!

We’re happy to announce that Charles and Lilly received the BRIDGE Discovery supporting HT-DISCOVER, an exciting new technology for detecting genome editing off-targets. HT-DISCOVER is a drop-in technology that works even in established genome editing workflows, enabling safer and more effective therapies. With the support of BRIDGE Discovery, Charles and Lilly will bring this innovative technology to market in a future spin-off.

Stay tuned for more information!

For potential collaborations and partnerships involving HT-DISCOVER, please contact Jacob Corn (jacob.corn@biol.ethz.ch) and Lilly van de Venn (lilly.vandevenn@biol.ethz.ch).

SUBMIT A COMMENT

Your email address will not be published. Required fields are marked *

Filters

Latest News

October 15, 2026

CRISPR IN CLINICAL ONCOLOGY: FROM RESEARCH TO CANCER DIAGNOSTICS AND THERAPIES – PUBLISHED IN NATURE REVIEWS CLINICAL ONCOLOGY

CRISPR technologies have transformed biomedical research, opening new possibilities for understanding, diagnosing, and treating cancer. But how close...

October 15, 2026

Choosing the right tool for precise genome editing – published in Nature Reviews Molecular Cell Biology

The genome-editing toolbox is rapidly expanding, offering increasingly diverse ways to make precise changes to DNA. But with so many emerging technologies,...

October 2, 2026

Corn lab retreat 2026

The Corn lab came together for this year’s retreat in Leysin, Vaud, on September 24–25. Over two engaging days, we combined science, reflection, and team building...

News Archive

Tweets